Semaglutide: Misuse of Diabetes 2 Medicine for Weight Loss



A drug called Semaglutide, which is sold under different brand names, was approved in 2017 to treat type 2 diabetes (T2D) and in 2021 (under a different brand name) for weight loss. This Type 2 diabetes medicine has become widely popular because of one of its side effects: weight loss. 

Both the buzz and surge in demand for semaglutide have created a shortage of the medicine, according to the U.S. FDA, which is expected to remain the same for several months, causing alarm among those with diabetes who rely on Semaglutide to help manage their blood sugar level. 

The non-diabetic individuals who are seeking slimmer waistlines are responsible for driving this growing demand. Experts caution that it’s crucial to understand Semaglutide is not a miracle medicine—and that there are risks to using the medicine outside of its intended use.

Endocrinologist Gregory Dodell, based in Central Park Endocrinology, stated that I`ve noticed an increase in Semaglutide inquiries from individuals. Dr Dodell regularly prescribes it to those with Type 2 diabetes (T2D), but he is hesitant in order to use the medicine in individuals with weight loss. 

"It works while individuals are using it, but once individuals stop, they gain back two-thirds of the weight they lost if not more, and occasionally weight loss plateaus, so individuals have to go off or stay on it for sure," he said.

Here’s what you need to know about the misuse of Semaglutide:

According to several reports, there is a possible existence of the issue of misuse of diabetes medication semaglutide. In line with this, in March 2023, the French National Agency for Drug Safety reported ‘boost surveillance’ levels for the medicine. In fact, since the month of September 2022, the medication agency has been cautioned/warned by a wide of videos on social platforms and by pharmacists reporting forged prescriptions and the use of the medicine for weight loss in non-diabetic individuals. 

The promotion of semaglutide as a weight-loss treatment on Social media platforms and the associated surge in demand may well have contributed to the current shortage of the drug. One could hypothesize that the non-realistic genres of physical attractiveness being promoted for otherwise healthy, non-obese individuals may be behind these putative levels of drug misuse. 

Conclusion:

The existing data, which manifests a possible misuse of semaglutide, will need to be confirmed by further empirical analysis. These will be helpful in better elaborating the GLP-1R agonists’ central pharmacodynamics, such as their interaction with other receptors, the levels of existence of agonists GLP1-R for acquisition from rogue websites, and, with the help of precisely planned epidemiological researches/studies, the features of their potential misuse in general as well as vulnerable populations.

Reference:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384093/

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found to b
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or wit
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphamide, e
Read more